eEF2K plays a key role in the response to DNA damaging stress and has been reported to regulate the sensitivity of cancer cells to several therapeutic drugs, including 2-DG, velcade, curcumin, TRAIL and temozolomide [9, 11-13]. The gene discussed is TNFSF10; the disease is cancer.